LetterLETTER
Polymer Embolism from Bioactive and Hydrogel Coil Embolization Technology: Considerations for Product Development
A.M. Chopra, J.P. Cruz and Y.C. Hu
American Journal of Neuroradiology July 2019, 40 (7) E34-E35; DOI: https://doi.org/10.3174/ajnr.A6083
A.M. Chopra
aChemical Engineer/Medical Researcher
Camarillo, California
J.P. Cruz
bDepartment of Radiology
Hospital Clínico de la Pontificia Universidad Católica de Chile
Santiago, Chile
Y.C. Hu
cDepartment of Neurosurgery
University Hospitals Cleveland Medical Center
Cleveland, Ohio

REFERENCES
- 1.↵
- Reinges MH,
- Krings T,
- Drexler AY, et al
- 2.↵
- 3.↵
- 4.↵U.S. Food and Drug Administration Safety Communications. Lubricious Coating Separation from Intravascular Medical Devices: FDA Safety Communication. November 23, 2015. http://wayback.archive-it.org/7993/20170404182155/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm473794.htm. Accessed January 13, 2019.
- 5.↵U.S. Food and Drug Administration. Recognized Consensus Standards. Recognition number 3–99, AAMI TIR42:2010. Evaluation of Particulates Associated with Vascular Medical Devices. Updated September 17, 2018. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/detail.cfm?standard__identification_no=38909. Accessed 13 January 13, 2019.
In this issue
American Journal of Neuroradiology
Vol. 40, Issue 7
1 Jul 2019
Advertisement
Polymer Embolism from Bioactive and Hydrogel Coil Embolization Technology: Considerations for Product Development
A.M. Chopra, J.P. Cruz, Y.C. Hu
American Journal of Neuroradiology Jul 2019, 40 (7) E34-E35; DOI: 10.3174/ajnr.A6083
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement